RiteshRajeshKotechaMDMD

Genitourinary Oncology

Physician

Overview of Dr. Kotecha

Dr. Ritesh Kotecha is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Sloan Kettering Bergen. He received his medical degree from Albany Medical College and has been in practice 6 years. He is one of 497 doctors at Memorial Sloan Kettering Cancer Center and one of 16 doctors at Memorial Sloan Kettering Bergen who specialize in Oncology. He has more than 40 publications and over 500 citings.

Office
353 East 68th Street
New York, NY 10065
Book by Phone+1(415) 801-3296

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2017 - 2020
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2014 - 2017
Albany Medical CollegeClass of 2014, MD

Certifications & Licensure

FL State Medical License 2021 - Present
NY State Medical License 2017 - 2026
NJ State Medical License 2020 - 2025
PA State Medical License 2023 - 2024
MA State Medical License 2014 - 2017
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer Start of enrollment: 2020 Apr 06
Active, not recruiting
Phase 1, Phase 2
Roles: Principal Investigator, Contact
Talazoparib and Avelumab in Participants With Metastatic Renal Cell Carcinoma Start of enrollment: 2019 Aug 22
Completed
Phase 2
Roles: Contact, Principal Investigator
A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain Start of enrollment: 2023 Nov 10
Recruiting
Phase 1
Roles: Principal Investigator, Contact

Publications & Presentations

PubMed

Sample Site Impacts RNA Biomarkers for Renal Cell Carcinoma.
Lennert Eismann, Amy X Xie, Cerise Tang, Andrea Knezevic, Irina Ostrovnaya
European Urology. 2025-01-01
Corrigendum to "Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase II Trial" [Eur. Urol. 86(2) (2024) 90-94].
Kelly N Fitzgerald, Chung-Han Lee, Martin H Voss, Maria I Carlo, Andrea Knezevic
European Urology. 2025-01-01
Prospective Study of Patient, Nursing, and Oncology Provider Perspectives on Telemedicine Visits for Renal Cell Carcinoma Clinical Trials.
Sahil D Doshi, Andrea Knezevic, Carlene Gonzalez, Patricia Fischer, Robert Goodman
Clinical Genitourinary Cancer. 2024-11-13

Press Mentions

CAR T-cell Therapy for Kidney Cancer Builds on Efficacy RecordNovember 9th, 2024
Memorial Sloan Kettering Awards and AppointmentsOctober 16th, 2020
Breaking down Genomic Data: An in-Depth Look at Ancestry and Tumor Biology in Kidney Cancer - Ritesh KotechaJuly 12th, 2023